Compliance Certificate under Reg 74(5) of SEBI (DP) Regulation
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma Ltd has submitted a compliance certificate under SEBI's Regulation 74(5) for the quarter ended 31st March 2025. The certificate was issued by the company's Registrar and Transfer Agent (RTA), Bigshare Services Private Limited, confirming that all securities received from depository participants for dematerialization during the quarter were properly verified and processed. The RTA also confirmed that physical share certificates received were mutilated and cancelled, and the depository names were updated in the register of members within the required 15-day timeline. The filing was signed by Director Prakash Shah on 11th April 2025.
This is a routine procedural compliance filing mandated by SEBI and has no direct material impact on shareholders or the company's stock price. It simply confirms that the company's share transfer and dematerialization processes are functioning in line with regulatory requirements.